MedTrace Logo

Micellar Curcumin and Metabolic Syndrome Biomarkers

NCT01925547 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2016-10-25

No results posted yet for this study

Summary

The purpose of this study is to investigate the effect of micellar curcumin on inflammation and lipid metabolism markers in subjects at risk for the metabolic syndrome.

Conditions

  • Metabolic Syndrome, Protection Against

Interventions

DIETARY_SUPPLEMENT

Micellar curcumin

80 mg micellar curcumin (oral) three times a day for six weeks

DIETARY_SUPPLEMENT

Placebo

Only the excipients (without curcumin) used to prepare the curcumin micelles are given as placebo.

Sponsors & Collaborators

  • German Federal Ministry of Education and Research

    collaborator OTHER_GOV

  • University of Hohenheim

    lead OTHER

Principal Investigators

  • Jan Frank, Ph.D. · University of Hohenheim

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2014-03-31
Completion
2014-10-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01925547 on ClinicalTrials.gov